COMMUNIQUÉS West-GlobeNewswire
-
Vera Therapeutics to Participate at Upcoming Investor Conferences
08/11/2024 - 14:00 -
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
08/11/2024 - 14:00 -
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
08/11/2024 - 14:30 -
Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates
08/11/2024 - 15:00 -
AVITA Medical to Host Investor Webinar Briefing
08/11/2024 - 15:00 -
Paratek Pharmaceuticals Announces Positive Top-Line Data from Phase 2b Study of Oral Omadacycline (OMC) in Nontuberculous Mycobacterial (NTM) Abscessus Pulmonary Disease
08/11/2024 - 15:00 -
Kineta Updates KVA12123 Clinical Results from Ongoing Phase 1/2 VISTA101 Study at Society for Immunotherapy of Cancer (2024)
08/11/2024 - 15:00 -
Director/PDMR Shareholding
08/11/2024 - 15:00 -
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
08/11/2024 - 15:07 -
Medigene Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024
08/11/2024 - 15:30 -
CervoMed Awarded the Prix Galien USA 2024 Prize for Best Startup
08/11/2024 - 15:55 -
Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
08/11/2024 - 16:00 -
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
08/11/2024 - 16:05 -
BioPorto Sponsors Exhibits to Showcase Launch of ProNephro AKI in the U.S. and Ongoing Marketing of The NGAL Test to Clinicians at Major Healthcare Conferences
08/11/2024 - 17:03 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024
08/11/2024 - 18:00 -
Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2024
08/11/2024 - 18:00 -
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024
08/11/2024 - 18:00 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
08/11/2024 - 18:00 -
Pearson Medical Technologies Introduces m:Print Bar Code Labeling Software v4 for Pharmacy Drug Supply Chain Security Act (DSCSA) Compliance
08/11/2024 - 18:23
Pages